The combined oral contraceptive pill (COCP) is a popular form of birth control, but it is not suitable for everyone. There are absolute contraindications, which mean that the COCP should not be used under any circumstances, and relative contraindications, which require careful consideration before prescribing.

Absolute contraindications include smoking 15 or more cigarettes a day and being over 35 years old, hypertension, major surgery with prolonged immobilization, secondary Raynaud’s disease, systemic lupus erythematosus, positive for antiphospholipid syndrome, current or history of venous thromboembolism, migraine with aura, current breast cancer, liver cirrhosis, viral hepatitis, and diabetic nephropathy/retinopathy/neuropathy.

Relative contraindications include smoking less than 15 cigarettes a day and being over 35 years old, being 6 weeks to 6 months postpartum and breastfeeding, being less than 21 days postpartum and not breastfeeding, having a body mass index of 35 or higher, having a family history of venous thromboembolism in a first-degree relative, having migraines without aura, having a history of breast cancer without recurrence for 5 years, using certain anticonvulsants, having dyslipidemia, undergoing rifampicin therapy, and having a previous use of methotrexate.

A history of pelvic inflammatory disease or prior ectopic pregnancy is not considered a contraindication to the use of the COCP. The possibility of a BRCA mutation is a controversial topic, and while there is evidence of a small increase in breast cancer risk with COCP use, it is not an absolute contraindication. It is important to consult with a healthcare provider to determine the best form of birth control for individual circumstances.

Contraception Options for Postpartum Women: A Guide for Healthcare Providers

Postpartum women have unique contraceptive needs and considerations. In this guide, we will discuss the various contraception options available for postpartum women and their suitability based on individual circumstances.

Progesterone-Only Pill

The progesterone-only pill is a safe option for women who are breastfeeding and < six weeks postpartum. It can be started immediately after delivery and is the first-line management for women who cannot take the combined oral contraceptive pill (COCP). The pill thickens mucous, preventing sperm from entering the uterus, and suppresses ovulation. However, compliance can be an issue, and long-acting progesterone contraceptives may be more appropriate. Combined Oral Contraceptive Pill (COCP) The COCP should not be used before six weeks postpartum in breastfeeding women and before 21 days in non-breastfeeding women. A risk assessment should be performed, and contraindications, such as smoking and age over 35, should be considered. Intrauterine System The intrauterine system is a highly effective long-acting reversible contraceptive that can be inserted at the time of delivery or within the first 48 hours postpartum. Delayed insertion until after four weeks postpartum is recommended to reduce the risk of uterine perforation. No Contraception Required Breastfeeding can suppress ovulation, but if a woman is not exclusively breastfeeding, contraception should be offered. The patient’s wishes should be established, and contraception should be discussed at the 6-week postpartum check. Tubal Ligation (Sterilisation) Tubal ligation is a permanent form of contraception that should not be considered until after six weeks postpartum. The patient should be counselled regarding the risks and benefits, the low success of reversibility, and the possibility of future desire for children. Male sterilisation should be considered first, and both partners should be present for the consultation. In conclusion, healthcare providers should consider individual circumstances and preferences when discussing contraception options with postpartum women. A thorough risk assessment and counselling should be performed before recommending any form of contraception.

Molluscum Contagiosum: Diagnosis and Treatment Options

Molluscum contagiosum is a viral skin disease that can be transmitted through sexual and non-sexual means. It results in flesh-colored, hemispherical papules with a central indentation, typically found on the genitalia, lower abdomen, and upper thighs. The incubation period is 3-12 weeks, and lesions can persist for up to two years before resolving on their own.

Diagnosis is made through clinical examination and electron microscopy of lesion particles. Treatment is not routinely recommended due to the self-resolving nature of the disease. However, cosmetic treatments such as benzoyl peroxide and podophyllotoxin may be used in adults with unsightly lesions on exposed areas or affecting quality of life.

Saline baths, acyclovir, corticosteroids, and metronidazole are not appropriate treatments for molluscum contagiosum. Saline baths are used for itch relief in conditions like eczema, acyclovir is for herpes zoster infection, corticosteroids are not recommended for viral skin diseases, and metronidazole is used for rosacea.

In conclusion, molluscum contagiosum is a viral skin disease that can be diagnosed through clinical examination and electron microscopy. Treatment is not routinely recommended, but cosmetic options may be used in certain cases. Other treatments, such as saline baths, acyclovir, corticosteroids, and metronidazole, are not appropriate for this condition.

During fertilization, the nucleus of the sperm carries the genetic material needed to create the paternal pronucleus and subsequently the zygote. The acrosome discharges its hydrolytic enzymes to help the sperm penetrate through the corona radiata and the zona pellucida. The sperm nucleus enters the cytoplasm of the egg, along with the midpiece, mitochondria, centrosome, and kinocilium of the sperm. Fertilization triggers changes in the chemistry of the zona pellucida and the discharge of cortical granules in the egg cytoplasm, which prevent additional sperm from fertilizing the egg. The sperm nucleus decondenses to form the haploid male pronucleus, which fuses with the haploid female pronucleus to form a diploid zygote nucleus. The midpiece and kinocilium of the sperm are destroyed, while the plasma membrane covering the tail remains attached to the egg plasma membrane. Mitochondrial diseases are inherited exclusively along the maternal line because the male mitochondria are destroyed soon after fertilization.

The progesterone-only pill (POP) is a suitable contraceptive option for this patient, especially since she is over 35 years old and a smoker. Other options to consider include the copper intrauterine device (IUD), the levonorgestrel IUS, and sterilization. Natural family planning may not be effective due to the patient’s irregular periods, which could be a sign of approaching menopause. Hormone replacement therapy (HRT) is not a contraceptive and therefore not recommended. Even though the patient is approaching menopause, she is still having periods, so contraception is still necessary. The combined oral contraceptive pill (COCP) is not advisable due to the patient’s age and smoking status, but the POP or implant could be considered.

The Timeline and Symptoms of Secondary Syphilis

Secondary syphilis is a multisystem disease that usually develops between 2 and 8 weeks following the appearance of a chancre. In women, chancres can be found on the labia, vulva, or cervix, making it easy to miss the primary stage.

Symptoms of secondary syphilis include mild fever, malaise, and headache. A rash on the trunk and limbs is also common, which may involve the palms and soles of the feet. If left untreated, the rash can last up to 12 weeks.

It’s important to note that clinical manifestations of secondary syphilis will resolve without treatment, but relapse may occur within the first year.

In summary, the timeline for secondary syphilis is between 2 and 8 weeks following the chancre, and symptoms include fever, malaise, headache, and a rash on the trunk and limbs. Early detection and treatment are crucial to prevent further complications.

Understanding Semen Analysis: Normal Values for Sperm Count, Volume, pH, Viability, and Motility

Semen analysis is a crucial test to evaluate male fertility. The World Health Organisation (WHO) has established reference values for semen parameters, including sperm count, volume, pH, viability, and motility.

The normal sperm count is 15 million per ml of ejaculate, and a sample should be submitted to the lab within an hour of collection for accurate results. A sperm count of 5 million per ml of ejaculate is considered low and may indicate infertility.

The semen volume should be 1.5 ml or more, and a volume of 3 ml per ejaculation is considered normal. The ejaculate pH should be 7.2 or more, and a pH below 7.0 may indicate an infection or obstruction in the reproductive tract.

Sperm viability refers to the percentage of live sperm in the sample. The normal viability is 58% or more live sperm, and a lower percentage may indicate poor sperm quality or function.

Sperm motility refers to the ability of sperm to move and swim towards the egg. The normal sperm should be 40% or more motile, and 32% or more should have progressive motility. A motility of 55% four hours after ejaculation is considered normal.

In conclusion, understanding the normal values for semen analysis can help diagnose male infertility and guide appropriate treatment options.

HIV: Transmission, Replication, and Types

HIV, or human immunodeficiency virus, is a virus that attacks the immune system and can lead to acquired immunodeficiency syndrome (AIDS). Here are some important facts about HIV transmission, replication, and types:

Transmission: HIV can be transmitted through certain body fluids, including blood, breast milk, and vaginal/seminal fluids. If these fluids come into contact with a mucous membrane or broken skin, HIV can be transmitted. This means that oral sex can also transmit HIV if vaginal/semen fluids come into contact with the oral cavity.

Replication: HIV is an RNA retrovirus that requires reverse transcriptase to replicate. It contains two copies of genomic RNA. When a target cell is infected, the virus is transcribed into a double strand of DNA and integrated into the host cell genome.

Types: HIV-1 is the most common type of HIV in the UK, whereas HIV-2 is common in West Africa. HIV-1 is more virulent and transmissible than HIV-2. Both types can be transmitted by blood and sexual contact (including oral sex).

Depletion of CD4 T cells: HIV principally targets and destroys CD4 T cells (helper T cells). As a result, humoral and cell-mediated responses are no longer properly regulated, and a decline in immune function results.

Overall, understanding how HIV is transmitted, replicates, and the different types can help in prevention and treatment efforts.

Differential Diagnosis of Genital Ulcer Disease: A Case of Chancroid

A patient presents with a genital ulcer, which has developed from a papule to a painful ulcer. The lesion is diagnosed as chancroid, a sexually transmitted disease caused by Haemophilus ducreyi. Chancroid is endemic in Asia, South America, and Africa, and typically presents as a single lesion in men and multiple lesions in women. Painful unilateral lymphadenopathy may be present, which can progress to suppurative buboes.

Other possible differential diagnoses include genital herpes, which produces multiple painful and itchy ulcers, and syphilis, which produces a single painless ulcer (chancre) at an early stage. However, due to the patient’s recent travel and the presence of pain, these are less likely diagnoses.

Donovanosis, or granuloma inguinale, is caused by Klebsiella granulomatis and produces multiple nodules that burst into painless ulcers. Inguinal lymphadenopathy is minimal, making this an unlikely differential. Lymphogranuloma venereum (LGV), caused by Chlamydia trachomatis, produces a painless ulcer at the contact site, but the patient’s ulcer is painful. In the second stage of LGV infection, painful lymphadenopathy and bubo development occur.

In conclusion, chancroid is the most likely diagnosis for this patient’s genital ulcer, and other differential diagnoses should be considered based on clinical presentation and travel history.

Understanding the Potential Risks and Side Effects of Female Sterilisation

Female sterilisation is a permanent contraceptive procedure that involves blocking the Fallopian tubes. While it is highly effective, it is important for women to understand the potential risks and side effects before undergoing the procedure.

Risks and Side Effects of Female Sterilisation

Explanation: Female sterilisation is a surgical procedure that permanently blocks the Fallopian tubes, preventing the passage of gametes. While it is a highly effective form of contraception, it is important for women to be aware of the potential risks and side effects before undergoing the procedure.

One of the main risks of female sterilisation is the possibility of ectopic pregnancy, which occurs when a fertilized egg implants outside of the uterus. While the risk is low, it is important for women to be aware of this potential complication.

Other risks and side effects of female sterilisation include complications during the procedure, such as the need for laparotomy under the same anesthesia, as well as the irreversibility of the procedure and the need to consider alternative contraceptive methods.

It is also important to note that depression is a rare side effect of hormonal contraceptives, but is not seen with interventional approaches such as tubal ligation. Similarly, while unprotected intercourse can increase the risk of sexually transmitted infections (STIs), it would be unreasonable to label STIs after tubal ligation as a complication.

Finally, weight gain is associated with hormonal contraceptives such as the combined oral contraceptive pill, but there is no evidence to suggest that tubal ligation causes weight gain. Women may also experience increased abdominal cramps during menstruation when using a non-hormonal intrauterine device (IUD) such as the copper IUD.

Overall, it is important for women to have a thorough understanding of the potential risks and side effects of female sterilisation before making a decision about whether or not to undergo the procedure.